Get started
Live feed
·
SECFilingvia Quantisnow
Traws Pharma Inc. logo

TRAW: Traws Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for TRAW

Across the 7 sessions after earlier TRAW headlines, the stock closed higher 2 times and lower 5 times, with a median move of 15.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

TRAW close-to-close change in the session after earlier headlines
SessionEarlier headlineTRAWSPY
Jan 26, 2026Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza+15.3%+0.5%
Jan 13, 2026Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients+26.8%-0.2%
Dec 17, 2025Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients-36.4%-1.1%
Dec 3, 2025H.C. Wainwright initiated coverage on Traws Pharma with a new price target-2.3%+0.3%
Nov 13, 2025Traws Pharma Reports Third Quarter 2025 Results and Business Highlights-17.3%-1.7%
Oct 30, 2025ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials-5.0%-1.1%
Quantisnow market dataNASDAQ
Traws Pharma Inc. logo
TRAW
Traws Pharma Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2013
Get push alerts for TRAW

Follow TRAW and get a push notification the moment its next story breaks.

Full TRAW profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAW (Traws Pharma Inc.) and more on Quantisnow.